feed,title,long_url,short_url
Benzinga,Opiant Pharma's Starts Dosing In Nasal Nalmefene Comparison Study For Remifentanil-Related Respiratory Depression,https://benzinga.com/general/biotech/21/04/20495117/opiant-pharmas-starts-dosing-in-nasal-nalmefene-comparison-study-for-remifentanil-related-respira,https://j.mp/3dSIHx1
Benzinga,Karyopharm Stock Is Trading Higher After China's NMPA Signs Off Early-Stage ATG-019 Study In Cancer Settings,https://benzinga.com/general/biotech/21/04/20494948/karyopharm-stock-is-trading-higher-after-chinas-nmpa-signs-off-early-stage-atg-019-study-in-cance,https://j.mp/3dCemCr
